Montelukast is
Montelukast is a medication, so the question is testing knowledge of its classification. The options probably include different types of drugs. The core concept here is pharmacology, specifically the classification of asthma and allergy medications. Montelukast is known to be a leukotriene receptor antagonist, which is a key point for exams like NEET PG or USMLE.
Now, why is D the correct answer? Leukotriene receptor antagonists work by blocking the action of leukotrienes, which are inflammatory mediators involved in asthma and allergic reactions. Montelukast specifically targets the cysteinyl leukotriene receptors (CysLT1), thereby reducing bronchoconstriction, mucus secretion, and inflammation. It's important to mention the receptors and the mechanism here.
The incorrect options would be other drug classes. For example, if the options included beta-2 agonists, corticosteroids, or H1 antagonists, each of those has a different mechanism. Let's say Option A is a beta-2 agonist like albuterol, which acts on beta-2 receptors to relax airways. Option B might be a corticosteroid, which reduces inflammation via glucocorticoid receptors. Option C could be an H1 antagonist like cetirizine, which blocks histamine. Each of these is incorrect because they don't block leukotrienes.
The clinical pearl here is that Montelukast is particularly used for long-term control of asthma and allergic rhinitis. It's not a rescue medication. Also, it's important to note that it's not effective for acute bronchospasm, which is a common exam trap. Students should remember that leukotriene modifiers are used for maintenance, not acute treatment.
Putting this all together, the explanation needs to be concise, hit all the key points, and fit within the character limit. I need to structure each section as specified: Core Concept, Why Correct, Why Incorrects, Clinical Pearl, and Correct Answer Line. Make sure to use bold for section headers and key terms. Avoid markdown except for bold. Check the character count to stay under 2500. Let me draft that now.
**Core Concept**
Montelukast is a **leukotriene receptor antagonist** used in asthma and allergic rhinitis. It inhibits cysteinyl leukotriene receptors (CysLT1), reducing airway inflammation and bronchoconstriction. This mechanism distinguishes it from beta-2 agonists, corticosteroids, or H1 antagonists.
**Why the Correct Answer is Right**
Montelukast blocks the binding of leukotrienes (e.g., LTC4, LTD4, LTE4) to CysLT1 receptors on airway smooth muscle and inflammatory cells. This prevents bronchoconstriction, mucus secretion, and eosinophilic inflammation. It is a **selective, oral antagonist** used for chronic disease management, not acute relief. Unlike corticosteroids, it does not suppress systemic immunity.
**Why Each Wrong Option is Incorrect**